Bruker Corp. buy Guggenheim
Start price
17.01.25
/
50%
€55.38
Target price
17.01.26
-
Performance (%)
-27.41%
End price
18.01.26
€40.20
Summary
This prediction ended on 18.01.26 with a price of €40.20. The prediction for Bruker Corp. disappointed with a performance of -27.41%. Guggenheim has a follow-up prediction for Bruker Corp. where he still thinks Bruker Corp. is a Buy. Dividends of €0.20 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bruker Corp. | 1.787% | 1.787% | -0.317% |
| iShares Core DAX® | 0.789% | 1.975% | 13.390% |
| iShares Nasdaq 100 | 4.226% | 4.344% | 39.717% |
| iShares Nikkei 225® | 3.285% | 6.991% | 49.894% |
| iShares S&P 500 | 2.496% | 2.759% | 30.229% |
Comments by Guggenheim for this prediction
In the thread Bruker Corp. diskutieren
Bruker Co. (NASDAQ: BRKR) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for BRKR provided by MarketBeat
In the thread Trading Bruker Corp.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten